[
  {
    "ts": null,
    "headline": "A Look At GE HealthCare Technologies (GEHC) Valuation After New Edge AI Partnership With NXP",
    "summary": "GE HealthCare Technologies (GEHC) is back in focus after announcing a collaboration with NXP Semiconductors to apply edge AI to anesthesia delivery and neonatal monitoring, with concept systems showcased at CES 2026. See our latest analysis for GE HealthCare Technologies. The NXP partnership and the upcoming February results arrive after a strong 90-day share price return of 20.77% and a three year total shareholder return of 31.22%. However, the one year total shareholder return is slightly...",
    "url": "https://finnhub.io/api/news?id=4e7738f218e8db5a74a106ac6f30ef3363c9e51a6d2557ea54663834573bc855",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767885481,
      "headline": "A Look At GE HealthCare Technologies (GEHC) Valuation After New Edge AI Partnership With NXP",
      "id": 138036982,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "GE HealthCare Technologies (GEHC) is back in focus after announcing a collaboration with NXP Semiconductors to apply edge AI to anesthesia delivery and neonatal monitoring, with concept systems showcased at CES 2026. See our latest analysis for GE HealthCare Technologies. The NXP partnership and the upcoming February results arrive after a strong 90-day share price return of 20.77% and a three year total shareholder return of 31.22%. However, the one year total shareholder return is slightly...",
      "url": "https://finnhub.io/api/news?id=4e7738f218e8db5a74a106ac6f30ef3363c9e51a6d2557ea54663834573bc855"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare price target raised to $95 from $90 at Stifel",
    "summary": "Stifel raised the firm’s price target on GE HealthCare (GEHC) to $95 from $90 and keeps a Buy rating on the shares. The firm, which argues that the 2026 setup is constructive for large-cap MedTech following 2025 pressures, adjusted targets among its coverage and highlights Boston Scientific (BSX), Edwards Lifesciences (EW), and Solventum (SOLV) as its three top ideas entering the year.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper dec",
    "url": "https://finnhub.io/api/news?id=c29e5c8200df0146dc50b42eb92197f8b8de5d0bf7c950ba4d16890527363c7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767876103,
      "headline": "GE HealthCare price target raised to $95 from $90 at Stifel",
      "id": 138037140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "Stifel raised the firm’s price target on GE HealthCare (GEHC) to $95 from $90 and keeps a Buy rating on the shares. The firm, which argues that the 2026 setup is constructive for large-cap MedTech following 2025 pressures, adjusted targets among its coverage and highlights Boston Scientific (BSX), Edwards Lifesciences (EW), and Solventum (SOLV) as its three top ideas entering the year.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper dec",
      "url": "https://finnhub.io/api/news?id=c29e5c8200df0146dc50b42eb92197f8b8de5d0bf7c950ba4d16890527363c7c"
    }
  }
]